EQL Pharma AB (publ) (FRA:7JK)

EQL Pharma AB Ratios and Metrics

Market cap in millions EUR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 23, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	165	190	107	97	94	97
Market Cap Growth	-19.06%	78.46%	10.31%	2.94%	-3.35%	170.17%
Enterprise Value	199	203	114	96	97	96
Last Close Price	5.44	6.58	3.39	3.35	3.15	-
PE Ratio	60.69	47.85	54.15	35.15	30.86	95.88
PS Ratio	4.18	5.53	4.65	4.18	2.38	5.55
PB Ratio	6.60	9.34	6.92	7.02	7.88	10.90
P/TBV Ratio	-	-	42.91	20.82	38.62	-
P/FCF Ratio	-	-	-	40.02	23.63	16.67
P/OCF Ratio	-	-	-	39.36	23.28	16.55
EV/Sales Ratio	4.98	5.90	4.99	4.14	2.47	5.47
EV/EBITDA Ratio	24.34	29.14	33.94	22.70	24.92	59.15
EV/EBIT Ratio	31.88	32.73	40.38	26.01	26.01	85.05
EV/FCF Ratio	-172.00	-	-	39.59	24.52	16.43
Debt / Equity Ratio	1.62	2.06	0.68	0.43	0.62	0.96
Debt / EBITDA Ratio	5.02	5.88	2.98	1.37	1.83	5.26
Debt / FCF Ratio	-	-	-	2.45	1.85	1.46
Net Debt / Equity Ratio	1.35	1.69	0.56	0.14	0.28	0.66
Net Debt / EBITDA Ratio	4.27	4.93	2.57	0.47	0.86	3.66
Net Debt / FCF Ratio	-29.15	-12.13	-8.06	0.82	0.85	1.02
Asset Turnover	0.67	0.63	0.80	0.99	1.86	1.09
Inventory Turnover	1.39	1.53	1.74	2.69	7.47	3.62
Quick Ratio	1.03	0.97	0.53	0.83	0.77	0.56
Current Ratio	2.16	1.81	1.22	1.43	1.25	1.03
Return on Equity (ROE)	12.28%	21.63%	13.66%	22.21%	29.37%	12.04%
Return on Assets (ROA)	6.53%	7.12%	6.18%	9.87%	11.00%	4.39%
Return on Invested Capital (ROIC)	8.35%	12.26%	11.40%	19.56%	21.96%	9.19%
Return on Capital Employed (ROCE)	10.40%	11.50%	15.40%	24.50%	27.90%	10.60%
Earnings Yield	1.65%	2.09%	1.85%	2.84%	3.24%	1.04%
FCF Yield	-0.70%	-1.49%	-1.01%	2.50%	4.23%	6.00%
Buyback Yield / Dilution	-0.22%	-0.34%	-0.91%	-1.59%	-	3.37%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.